Novavax Covid vaccine clears key step on path to FDA authorization after committee endorses the shot

Posted on AllSides June 8th, 2022
From The Center
Pavlo Gonchar | LightRocket | Getty Images

Novavax’s two-dose Covid-19 vaccine for adults ages 18 and older cleared a key step on the path toward Food and Drug Administration authorization on Tuesday.

The FDA’s committee of independent vaccine experts voted 21 to 0 with one abstention at the end of an all-day meeting to recommend authorizing the shot for use in the U.S. after an all-day public meeting in which it weighed safety and effectiveness data. The FDA usually follows the committee’s recommendations, though it is not obligated to do so. The agency could clear Novavax’s vaccine for distribution...

Read full story
Some content from this outlet may be limited or behind a paywall.


AllSides Media Bias Rating: Center
AllSides Media Bias Rating: Center
See full bias rating for CNBC
Learn about media bias

More News about Coronavirus from the Left, Center and Right

From the Left

From the Center

From the Right